title: (S)-oxybutynin (Sepracor).
abstract: Sepracor is developing (S)-oxybutynin, a single-isomer version of Alza's Ditropan (racemic oxybutynin), a muscarinic acetylcholine receptor antagonist, as a potential treatment for urinary incontinence.
authors.affiliation: Department of Urology, Vanderbilt University, Nashville, TN 37232, USA. roger.dmochowski@mcmail.vanderbilt.edu
authors.forename: Roger R
authors.initials: RR
authors.lastname: Dmochowski
mesh_terms: D000818:Animals; D002986:Clinical Trials as Topic; D006801:Humans; D008333:Mandelic Acids / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D018727:Muscarinic Antagonists / Q000627:therapeutic use*; D013329:Structure-Activity Relationship
chemical_list: D008333:Mandelic Acids; D018727:Muscarinic Antagonists; C005419:oxybutynin